Market Overview

Healthcare REITs Down On Brookdale, HCP Guidance

Healthcare REITs Down On Brookdale, HCP Guidance

Healthcare REITs were trading lower on Tuesday after HCP, Inc. (NYSE: HCP) and Brookdale Senior Living, Inc. (NYSE: BKD) issued troubling guidance.

HCP guided its fiscal 2016 FFO (Funds From Operations) per share to be in a range of $2.74 to $2.80. HCP's FFO for the full fiscal year 2015 was $2.72 per share.

Related Link: A Checkup On A Big Healthcare ETF

Brookdale Senior also issued 2016 guidance, and the company expects its full year fiscal 2016 CFFO to be in a range of $2.45 to $2.55 per share. The company's estimates fell short of the $2.62 per share Wall Street analysts were already estimating.

Shares of HCP were lower by more than 15 percent on Tuesday and hit a new 52-week low of $28.69, while shares of Brookdale Senior Living were also lower by around 15 percent and hit a new 52-week low of $11.28.

A source familiar with the matter told Benzinga that both HCP and Brookdale's poor guidance were pushing healthcare REITs lower on Tuesday.

Latest Ratings for BKD

Jan 2020BarclaysMaintainsEqual-Weight
Sep 2019BarclaysInitiates Coverage OnEqual-Weight
Oct 2018JMP SecuritiesMaintainsMarket OutperformMarket Outperform

View More Analyst Ratings for BKD
View the Latest Analyst Ratings


Related Articles (BKD + HCP)

View Comments and Join the Discussion!

Posted-In: Analyst Color Biotech News REIT Guidance Health Care Exclusives Analyst Ratings Best of Benzinga

Need corporate guidance data?
Click here to see licensing options.

Latest Ratings

IIPRRoth CapitalMaintains150.0
CRDFMaxim GroupMaintains14.0
KGCTD SecuritiesMaintains13.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at